GENMAB A/S (GMAB)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2027-02-01 | Phase3 Readout | — |
| 2027-03-01 | Phase2 Readout | — |
| 2027-07-01 | Phase2 Readout | — |
Active Clinical Trials (14)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT06952660 | Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer | PHASE4 | Recruiting | 100 |
| NCT06619236 | Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resi... | PHASE3 | Active Not Recruiting | 530 |
| NCT07225270 | Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Tre... | PHASE3 | Recruiting | 528 |
| NCT07166094 | Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With En... | PHASE3 | Recruiting | 660 |
| NCT06508658 | A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rit... | PHASE3 | Active Not Recruiting | 379 |
| NCT03485209 | Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors | PHASE2 | Active Not Recruiting | 350 |
| NCT03625037 | First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma | PHASE2 | Active Not Recruiting | 666 |
| NCT04663347 | Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL) | PHASE2 | Active Not Recruiting | 543 |
| NCT05579366 | Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) | PHASE2 | Recruiting | 884 |
| NCT07539311 | Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers | PHASE2 | Recruiting | 160 |
| NCT07288177 | Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer | PHASE2 | Recruiting | 240 |
| NCT05451810 | A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Part... | PHASE2 | Active Not Recruiting | 184 |
| NCT07384715 | First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelod... | PHASE1 | Recruiting | 78 |
| NCT06057038 | A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors | PHASE1 | Active Not Recruiting | 8 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.